ASCGX | VSGAX | ASCGX / VSGAX | |
Total Expense Ratio | 2.48 | 0.07 | 3,543% |
Annual Report Gross Expense Ratio | 2.48 | 0.07 | 3,543% |
Fund Existence | 22 years | 14 years | - |
Gain YTD | 12.206 | 9.269 | 132% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100 | 3000 | 3% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 17.7M | 39.1B | 0% |
Annual Yield % from dividends | 1.15 | 0.56 | 206% |
Returns for 1 year | 15.15 | 14.09 | 108% |
Returns for 3 years | 42.43 | 56.27 | 75% |
Returns for 5 years | -16.18 | 33.35 | -49% |
Returns for 10 years | 21.66 | 151.80 | 14% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PMFB | 26.14 | N/A | N/A |
PGIM S&P 500 Max Buffer ETF - February | |||
THQ | 18.17 | -0.07 | -0.38% |
abrdn Healthcare Opportunities Fund | |||
ITDB | 33.03 | -0.14 | -0.41% |
iShares LifePath Target Date 2030 ETF | |||
HEEM | 34.10 | -0.31 | -0.90% |
iShares Currency Hedged MSCI Em Mkts ETF | |||
AVUV | 98.65 | -1.22 | -1.22% |
Avantis US Small Cap Value ETF |